NMR spectroscopy for the elucidation of conformation and communication networks within and between proteins and nucleic acids. University of Colorado, USA
Our newly published paper with the @dalessandrolab identifies the #PIMT (PCMT1) V120I variant as crucial for enhancing red blood cell storage and reducing hemolysis, highlighting its potential in improving #RBC preservation. #NMR@LabVogeli
https://t.co/mxlTyy1tZc
We are excited to announce the first in-person “A to Z Meeting - Ludwig Conference on Alternative Nucleic Acid Conformations in Health and Disease.” September 28th-October 2nd, Oxford, UK #RNA
For registration, visit the website:
https://t.co/nnTHKb3JJb
We uncover the first evidence that the long-mysterious Zβ domain of ADAR1 binds G-quads, a surprising twist that reshapes how we think about ADAR targeting—opening new directions for understanding the links between innate immunity and splicing regulation.
https://t.co/AeRpUIDp74
New paper from our lab
Cromolyn, an #FDA-approved drug, binds selectively to ADAR1p150—revealing a new pharmacophore to tune #RNA editing & immune signaling in #Cancer. @CUCancerCenter@CU_BMG Collab w/ Rincon & Quentin Vicens labs @qvicens@LabVogeli
https://t.co/4KGTjqQNz6
New paper from our lab
Cromolyn, an #FDA-approved drug, binds selectively to ADAR1p150—revealing a new pharmacophore to tune #RNA editing & immune signaling in #Cancer. @CUCancerCenter@CU_BMG Collab w/ Rincon & Quentin Vicens labs @qvicens@LabVogeli
https://t.co/4KGTjqQNz6
TENURE-TRACK FACULTY POSITION
Department of Biochemistry and Molecular Genetics
University of Colorado Anschutz Medical Campus. #EM#Structural@CUAnschutz@CU_BMG